切换至 "中华医学电子期刊资源库"

中华胸部外科电子杂志 ›› 2017, Vol. 04 ›› Issue (04) : 249 -252. doi: 10.3877/cma.j.issn.2095-8773.2017.04.11

所属专题: 文献

综述

肺移植术后的长期管理策略
潘旭峰1, 翁薇琼1, 傅世杰1, 杨骏1, 曹克坚1, 赵珩1,()   
  1. 1. 200030 上海交通大学附属胸科医院胸外科
  • 收稿日期:2016-11-30 出版日期:2017-11-28
  • 通信作者: 赵珩
  • 基金资助:
    上海市卫计委局青课题(20144Y0169)

The strategy of long-term management after lung transplantation

Xufeng Pan1, Weiqiong Weng1, Shijie Fu1, Jun Yang1, Kejian Cao1, Heng Zhao1,()   

  1. 1. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China
  • Received:2016-11-30 Published:2017-11-28
  • Corresponding author: Heng Zhao
  • About author:
    Corresponding author: Zhao Heng, Email:
引用本文:

潘旭峰, 翁薇琼, 傅世杰, 杨骏, 曹克坚, 赵珩. 肺移植术后的长期管理策略[J/OL]. 中华胸部外科电子杂志, 2017, 04(04): 249-252.

Xufeng Pan, Weiqiong Weng, Shijie Fu, Jun Yang, Kejian Cao, Heng Zhao. The strategy of long-term management after lung transplantation[J/OL]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2017, 04(04): 249-252.

在过去30年中,肺移植的围术期病死率和短期存活情况得到极大的改善。但是肺移植术后的远期存活相对于其他实体器官移植仍然较低,而且一直没有明显改善,因此即便在肺移植患者度过了围术期后,仍然需要对其进行严格、科学地管理。肺移植后的主要并发症包括感染、排异反应、气道并发症、淋巴细胞增殖性疾病等,尽可能地预防或者及时发现可能出现的并发症并及时处理,对于改善肺移植患者的远期存活非常重要。

In the past 30 years, the perioperative mortality and short-term survival were greatly improved. When compared to the other solid organ transplantations, the long-term survival of lung transplantation did not increase a lot. Even if the patients could get through the perioperative period and discharged, we should strictly continue the postoperative management. The major complications after lung transplantation include infection, immunological rejection, airway complications, lymphopro-liferative disorder, etc. We should try our best to prevent or find the clues of possible complication, and it was very important to improve the long-term survival.

1
Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009[J]. J Heart Lung Transplant, 2009, 28(10): 1031-1049.
2
Chan CC, Abi-Saleh WJ, Arroliga AC, et al., Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients[J]. J Heart Lung Transplant, 1996, 15(2): 196-205.
3
Kanj SS, Tapson V, Davis RD, et al. Infections in patients with cystic fibrosis following lung transplantation[J]. Chest, 1997, 112(4): 924-930.
4
Dengler TJ, Strnad N, Bühring I, et al., Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation[J]. Transplantation, 1998, 66(10): 1340-1347.
5
Reams BD, Musselwhite LW, Zaas DW, et al. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation[J]. Am J Transplant, 2007, 7(12): 2802-2808.
6
Villanueva J, Bhorade SM, Robinson JA, et al. Extracorporeal photopheresis for the treatment of lung allograft rejection[J]. Ann Transplant, 2000, 5(3): 44-47.
7
Meloni F, Cascina A, Miserere S, et al. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients[J]. Transplant Proc, 2007,39(1): 213-217.
8
Cahill BC, O’Rourke MK, Strasburg KA, et al., Methotrexate for lung transplant recipients with steroid-resistant acute rejection[J]. J Heart Lung Transplant, 1996,15(11): 1130-1137.
9
Keenan RJ, Iacono A, Dauber JH, et al., Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients[J]. J Thorac Cardiovasc Surg, 1997, 113(2):335-340; discussion 340-341.
10
Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria[J]. J Heart Lung Transplant, 2002, 21(3):297-310.
11
Neurohr C, Huppmann P, Samweber B, et al., Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients[J]. J Heart Lung Transplant, 2009,28(5):468-474.
12
Gabbay E, Walters EH, Orsida B, et al. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase[J]. Am J Respir Crit Care Med, 2000,162(6): 2182-2187.
13
Stanbrook MB, Kesten S. Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans[J]. Am J Respir Crit Care Med, 1999,160(6): 2034-2039.
14
Golocheikine AS, Saini D, Ramachandran S, et al. Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation[J]. Transpl Immunol, 2008 ,18(3): 260-263.
15
Kawut SM, Lederer DJ, Keshavjee S, et al. Outcomes after lung retransplantation in the modern era[J]. Am J Respir Crit Care Med, 2008. 177(1): 114-120.
16
Santacruz JF, Mehta AC. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis[J]. Proc Am Thorac Soc, 2009, 6(1): 79-93.
17
Ruttmann E, Ulmer H, Marchese M, et al. Evaluation of factors damaging the bronchial wall in lung transplantation[J]. J Heart Lung Transplant, 2005,24(3):275-281.
18
Herrera JM, McNeil KD, Higgins RS, et al., Airway complications after lung transplantation: treatment and long-term outcome[J]. Ann Thorac Surg, 2001, 71(3): 989-993; discussion 993-994.
19
Alvarez A, Algar J, Santos F, et al., Airway complications after lung transplantation: a review of 151 anastomoses[J]. Eur J Cardiothorac Surg, 2001,19(4): 381-387.
20
Holmes RD, Sokol RJ. Epstein-Barr virus and post-transplant lymphoproliferative disease[J]. Pediatr Transplant, 2002, 6(6): 456-464.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 曾雪灵, 杨思园, 常宇飞, 赵红心, 王凌航. 176例人类免疫缺陷病毒合并肺部感染者呼吸道病原体特点与免疫学特征[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 142-148.
[3] 中华医学会器官移植学分会. 中国肺移植气道并发症临床诊疗指南(2024版)[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 266-274.
[4] 黄莹, 李璇, 刘梦杨, 彭桂林, 徐鑫, 韦兵, 杨超. 靶向联合治疗双肺移植术后KRAS和BRAF基因双突变晚期肺腺癌一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 298-301.
[5] 寇宛婷, 蔡英华, 周海琴, 吴琼. 肺移植术后谵妄影响因素的范围综述[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 251-256.
[6] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[7] 董大红, 周明虎, 李芝朋, 许正峰. 碳青霉烯类抗生素联合呼吸机治疗肺部感染的临床疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 793-796.
[8] 郑玉, 许振浪, 陈青青. 类鼻疽致肺部感染患者的治疗及药学监护分析一例[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 670-672.
[9] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[10] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[11] 张英信, 林婷, 张剑文. 构建靶向HLA-A2且表达PD-L1的CAR-Treg细胞及验证其对CD4+T细胞抑制作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 719-728.
[12] 苏生林, 马金兰, 于弘明, 杨晓军. 单细胞测序技术在脓毒症免疫研究中的应用进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 279-286.
[13] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[14] 叶禾清, 李杰, 张玉元, 胡炉淇, 吴白露, 李鑫, 叶书文, 李一帆, 高玥, 詹鹏超, 吕培杰, 李臻. 载药微球化疗栓塞联合多纳非尼及PD-1治疗中晚期大肝癌的疗效分析[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 212-216.
[15] 李子健, 王锐, 钟云鹏, 张迪轩, 梁韵娟, 杨超, 何建行, 李树本. 自体肺移植术在胸部恶性肿瘤中的临床应用[J/OL]. 中华胸部外科电子杂志, 2024, 11(03): 193-200.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?